科研之友ScholarMate
免费注册
首页 论文 论文详情
赞 收藏 引用

A randomized, double-blind, active-and placebo-controlled phase 3 study of efficacy and safety of ixekizumab, adalimumab, and placebo therapy in patients naive to biologic disease-modifying antirheumatic drugs with active psoriatic arthritis

作者：Mease P J; van der Heijde D; Ritchlin C T; Cuchacovich R S; Shuler C L; Lin C; Vangerow H; Samanta S; Lee C H; Gladman D D
来源：44th Annual Meeting of the Arbeitsgemeinschaft-Dermatologische-Forschung (ADF), 2017-03-09 to 2017-03-11.
收藏 分享 被引 浏览
更新时间：2018-01-23 05:21